Gene: KLHL7
Official Full Name: kelch like family member 7provided by HGNC
Gene Summary: This gene encodes a BTB-Kelch-related protein. The encoded protein may be involved in protein degradation. Mutations in this gene have been associated with retinitis pigmentosa 42. [provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21512 | KLHL7 Knockout cell line (HeLa) | Human | KLHL7 | 1:3~1:6 | Negative | Online Inquiry |
KO21513 | KLHL7 Knockout cell line (HCT 116) | Human | KLHL7 | 1:2~1:4 | Negative | Online Inquiry |
KO21514 | KLHL7 Knockout cell line (HEK293) | Human | KLHL7 | 1:3~1:6 | Negative | Online Inquiry |
KO21515 | KLHL7 Knockout cell line (A549) | Human | KLHL7 | 1:3~1:4 | Negative | Online Inquiry |
KLHL7 Gene Knockout Cell Lines are genetically engineered cell lines in which the KLHL7 gene has been deliberately disrupted or 'knocked out.' This innovative product is designed to facilitate advanced research in gene function, protein interaction, and associated cellular pathways, which are crucial for understanding various biological processes and disease mechanisms.
The primary function of KLHL7 Knockout Cell Lines revolves around the validation of gene function and exploration of its role in cellular activities. The knockout approach utilizes CRISPR-Cas9 technology or other gene-editing methods to create a loss-of-function model, allowing scientists to study the phenotypic consequences of KLHL7 gene deletion. By examining these cells, researchers can uncover insights into the pathways in which KLHL7 is involved, including its potential role in cellular growth, differentiation, and apoptosis.
The scientific importance of KLHL7 Knockout Cell Lines lies in their potential applications in both research and clinical settings. They are invaluable for studying diseases where KLHL7 is implicated, such as certain cancers or neurodegenerative disorders. This product serves as a vital tool for pharmacological screening, biomarker discovery, and the development of targeted therapies.
Compared to alternative products, KLHL7 Gene Knockout Cell Lines offer precise gene editing with a predictable outcome, resulting in more reliable data for researchers. In contrast, traditional methods, such as RNA interference, may yield incomplete knockdown or off-target effects, complicating experimental results. The KLHL7 knockout model provides researchers with a clean genetic background, which enhances reproducibility and interpretability of findings.
For researchers and clinicians, the introduction of KLHL7 Gene Knockout Cell Lines represents a significant advancement in genetic research and therapeutic development. These cell lines empower users to dissect intricate biological questions with enhanced clarity and precision, ultimately contributing to the broader understanding of gene functions in health and disease.
With a strong foundation in genetic engineering and a commitment to quality, our company specializes in providing cutting-edge biological products, including KLHL7 Gene Knockout Cell Lines, to support the scientific community's quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.